Allard, Nicole L.
MacLachlan, Jennifer H.
Dev, Anouk
Dwyer, James
Srivatsa, Geeta
Spelman, Timothy
Thompson, Alexander J.
Cowie, Benjamin C.
Funding for this research was provided by:
Royal Melbourne Hospital (PG-014-2016)
Article History
Received: 22 December 2019
Accepted: 11 March 2020
First Online: 7 May 2020
Ethics approval and consent to participate
: Ethics approval was granted by HREC committees at Melbourne Health, Western Hospital, St Vincent’s Hospital and Monash Health.
: NA, BC JD, JM, TS and GS have no competing interests to declare.AD has received money for Speaking Services: Bayer Pharmaceuticals, Bristol Myers Squibb Pharmaceuticals, Gilead Sciences, Janssen Pharmaceuticals, Merck Australia, Roche Pharmaceuticals, W.L Gore and Associates. Consultant for: Bayer Pharmaceuticals, Merck Australia. Advisory board membership: ABBVIE Pharmaceuticals, Bayer Pharmaceuticals. Research Support: Bayer Pharmaceuticals, Bristol Myers Squibb Pharmaceuticals, Gilead Sciences, Merck Australia, Roche Pharmaceuticals.AT is an Advisory board member: AbbVie, Bristol–Myers Squibb, Gilead Sciences, Janssen, Merck Sharp & Dohme and Roche Diagnostics. Speaker: AbbVie, Bristol–Myers Squibb, Gilead Sciences, and Merck Sharp & Dohme. Principal investigator: Bristol–Myers Squibb, Gilead Sciences, Janssen, Merck Sharp & Dohme, Roche and Spring Bank, Arrowhead. Receives research/grant support: AbbVie, Bristol–Myers Squibb, Gilead Sciences, Merck Sharp & Dohme.